Here we show that an actin depolymerising agent, Cyt D, reduces cell size and shape, inactivates RhoA and induces expression of E-cadherin, defining the actin cytoskeleton as an upstream regulator of EMT in metastatic cancer cells. The gene discussed is CDH1; the disease is metastatic malignant neoplasm.